{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "3193610",
  "DateCompleted": {
    "Year": "1989",
    "Month": "01",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "jpn"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0021-4949",
      "JournalIssue": {
        "Volume": "34",
        "Issue": "12",
        "PubDate": {
          "Year": "1988",
          "Month": "Oct"
        }
      },
      "Title": "Gan no rinsho. Japan journal of cancer clinics",
      "ISOAbbreviation": "Gan No Rinsho"
    },
    "ArticleTitle": "[The effect of naproxen on fever following transcatheter arterial embolization of hepatic tumors].",
    "Pagination": {
      "StartPage": "1659",
      "EndPage": "1662",
      "MedlinePgn": "1659-62"
    },
    "Abstract": {
      "AbstractText": [
        "In the cases of trans-catheter arterial embolization (TAE) for hepatic malignancies, naproxen has been evaluated for its antipyretic effect. Each patient not given naproxen manifested a remarkable and prolonged fever despite treatment by antibiotics. In those who received an administration of naproxen, however, a significant suppression of fever was achieved (P 0.01-0.001). No remarkable influence was found on the white blood cell counts, the serum GOT and LDH levels by the naproxen. Similarly, no untoward effect due to naproxen was found on the ulcerogenicity in the gastro-duodenum. Thus, for hepatic malignancies, naproxen could be useful in the symptomatic treatment of a fever following a TAE."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "1st Dept. of Surgery, School of Med., Chiba Univ."
          }
        ],
        "LastName": "Miyazaki",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Shimura",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Takahashi",
        "ForeName": "O",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kurihara",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Udagawa",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Koshikawa",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Itoh",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kanno",
        "ForeName": "Y",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Teramoto",
        "ForeName": "O",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kaiho",
        "ForeName": "T",
        "Initials": "T"
      }
    ],
    "PublicationTypeList": [
      "English Abstract",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Japan",
    "MedlineTA": "Gan No Rinsho",
    "NlmUniqueID": "1257753",
    "ISSNLinking": "0021-4949"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "57Y76R9ATQ",
      "NameOfSubstance": "Naproxen"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Embolization, Therapeutic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hepatic Artery"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "secondary",
        "therapy"
      ],
      "DescriptorName": "Liver Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Naproxen"
    }
  ]
}